Nanoscope’s BLA has been granted rolling review by the FDA, with the first modules already submitted. The completion of the ...

Nanoscope Therapeutics begins rolling submission of BLA to US FDA for gene-agnostic therapy, MCO-010 to treat retinitis pigmentosa: Dallas, Texas Wednesday, July 16, 2025, 14:30 H ...

Nanoscope Therapeutics submitted the first modules of a biologics license application for MCO-010, an investigational gene ...

Scientists at the Jules Stein Eye Institute at the David Geffen School of Medicine at UCLA have discovered that certain ...

Retinitis pigmentosa RP is a collection of inherited eye diseases that cause progressive vision loss It causes degeneration ...

If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

New research shows that retinal neurons can rewire to preserve vision in retinitis pigmentosa, a genetic disease causing blindness.

UCLA scientists found that in early retinitis pigmentosa, rod bipolar cells in mice rewire to connect with cones, preserving ...

Jenny Stafford, who has retinitis pigmentosa, completed her 250th parkrun in Jersey and says the regular activity makes a huge difference to her week. | ITV News Channel ...